Lipoprotein-associated phospholipase A2 (LP-PLA2) is an important inflammatory enzyme that leads to abnormal secretion of proinflammatory factors, and numerous epidemiological studies have shown that it is an independent predictor of cardiovascular events (CVEs), which can effectively assess the prognosis of cardiovascular disease (CVD) patients [11, 12]. Here, PLA2G7 is linked to cardiovascular disorder.